双链杂交分子“胰岛素—类胰岛素生长因子—I”

以去Ｂ链Ｃ端八肽胰岛素和化学合成的ＩＧＦ－Ｉ的２２－２９及２２－３２为底物,用酶促半合成方法制备了杂交分子“胰岛素－类胰岛素茵子－Ｉ”,Ｉｎｓ／ＩＧＦ－Ｉ和Ｉｎｓ－ＩＧＦ－Ｉ。研究了它们的胰岛中生物活性。结果表明,猪胰岛素Ｂ链Ｃ端Ｂ２７的Ｔｈｒ被Ａｓｎ取代,Ｂ３０的Ａｌａ被Ａｌａ被Ｔｈｒ取代同时Ｂ２５－Ｂ２６及Ｂ２８－Ｂ２９氨基酸顺序颠紧及在Ｂ链Ｃ末端延长３肽都不影响胰岛素的生物活力。     

双链杂交分子“胰岛素－类胰岛素生长因子－I

以去Ｂ链Ｃ端八肽胰岛素（ＤＯＩ）和化学合成的ＩＧＦ－Ｉ的２２～２９（８肽）及２２－３２（１１肽）为底物,用酶促半合成方法制备了杂交分子“胰岛素－类胰岛素生长因子－Ｉ,Ｉｎｓ／ＩＧＦ－Ｉ（８）和Ｉｎｓ／ＩＧＦ－Ｉ（１１）。研究了它们的胰岛素生物活性,结果表明,猪胰岛素Ｂ链Ｃ端Ｂ２７的Ｔｈｒ被Ａｓｎ取代,Ｂ３０的Ａｌａ被Ｔｈｒ取代同时Ｂ２５～Ｂ２６及Ｂ２８－Ｂ２ｋ９氨基酸顺序颠倒以及在Ｂ链Ｃ末端延长３肽（Ｇｌｙ－Ｔｙｒ－Ｇｌｙ）都不影响胰岛素的生物活力。     

类胰岛素生长因子-Ⅰ和胰岛素表现其功能的结构和分子基础

综述了近年来关于IGF-Ⅰ和胰岛素表现生理功能的结构基础和分子基础研究进展.IGF-Ⅰ和胰岛素是胰岛素家族中的2个重要成员, 两者的分子结构高度同源, 两者的受体相似且属同一家族, 两者的生理功能可彼此交叉, 但各自具有主要的生理功能.IGF-Ⅰ的主要生理功能是促进细胞生长, 胰岛素的主要生理功能是促进葡萄糖的摄取和代谢.生物大分子的功能及其表现的基础是分子结构及参与功能表现的诸多分子, 如受体、信号分子等等.     

胰岛素的促生长作用

除了经典的代谢调节作用之外,胰岛素还具有重要的促生长作用：在体外胰岛素能够刺激众多细胞的增殖与分化,一些实验证明胰岛素在体内可能也是一种重要的生长调节因子.胰岛素的促生长作用通过细胞表面的胰岛素受体介导,但在较高的胰岛素浓度下也可以通过类胰岛素生长因子Ⅰ(IGF-Ⅰ)受体进行,在不同细胞体系中可能会有所不同.受体后的信号转导经过了一系列磷酸化和去磷酸化等途径,其中有胰岛素受体底物1(IRS-1)、Shc蛋白、Ras蛋白以及磷酸肌醇3激酶(PI3-K)等的参与.在胰岛素的分子表面很可能存在一些区域或位点,对其促生长作用有着更大的贡献,通过对一些高促生长活性的胰岛素类似物的研究已揭示出一些初步的证据.     

虹鳟胰岛素样生长因子Ⅰ和Ⅱ在大肠杆菌中的融合表达及促有丝分裂活性

The preparation of recombinant rainbow trout insulin like growth factorsⅠ(IGF Ⅰ) andⅡ(IGF Ⅱ) using the His6 fusion polypeptide technique and the mitogen ic activities of these compounds were investigated. Rainbow trout IGF Ⅰand IGF ⅡB C A D domain cDNA were subcloned into expression vector pET 15b (Nova gen, USA) and expressed in host E. coli BL21 (DE3) as fusion polypeptides co ntai ning a stretch of 6 histidines at the N terminus (referred as His6 fusion polyp e ptide). The addition of IPTG (0 4 mmol/L) induced the expression of polypeptide s with a molecular weight of about 10 0 kDa. The expressed proteins were ammoniu m sulfate fractionally precipitated and further purified using a Ni 2+ His ·Bind R esin (Novagen, USA) affinity column. The reduced SDS PAGE showed that IGF Ⅰ w as of 80% purity and IGF Ⅱ was of 90% purity. The rainbow trout IGF Ⅰ His6 fusi on polypeptide showed dose dependent mitogenic effects on BALB/NIH3T3 cells in th e serum free medium culture, and rainbow trout IGF Ⅱ His6 fusion polypeptide al s o showed this kind of activity, but with lower potency. Taken together,these re sults indicated that the rainbow trout IGF Ⅰ and ⅡHis6 fusion polypeptides pr o duced in E. coli were biologically active, with IGF Ⅰ His6 fusion polypept ide of higher potency.     

团头鲂胰岛素样生长因子-Ⅰ基因克隆与分析

胰岛素样生长因子－Ⅰ（IGF－Ⅰ）是一单链多肽。在脊椎动物中,IGF－Ⅰ通过介导生长激素达到促进生长的作用。为研究鲤科鱼类IGF－Ⅰ的结构功能及在水产养殖中的潜在应用前景,采用逆转录－聚合酶链式反应（RT－PCR）方法,从团头鲂（Megalobrama amblycephala）肝脏的总RNA中扩增出IGF－Ⅰ cDNA。测定了该基因序列,推导其编码的蛋白质序列,克隆的cDNA序列编码包括信号肽和B、C、A、D、E6个区域的161个氨基酸。E区域分析结果表明所克隆的团头鲂IGF－Ⅰ序列属于IGF－ⅠEa-2亚型。     

胰岛素B链C端及B29Lys氨基在胰岛素促生长功能中的 …

利用结晶紫测定细胞生长的方法,在９６孔板培养的小鼠乳腺癌细胞ＧＲ２Ｈ６中,建立了胰岛素促细胞生长活力的测定体系。该方法具有灵敏度高,重复性好,操作简便,周期短及便于大量样品分析测试的优点。利用该方法研究了胰岛素Ｂ链Ｃ端延长与缩短的类似物和胰岛素侧链氨基对胰岛素促生长活性的影响。结果显示,胰岛素Ｂ链Ｃ端在胰岛素的促生长活性中有重要作用;Ｂ链２９Ｌｙｓ氨基对促生长活性也有较大贡献。     

鸡类胰岛素生长因子-Ⅱ基因单核苷酸多态与生长、屠体性状相关性的研究

以鸡类胰岛素生长因子-Ⅱ（IGF-Ⅱ）基因作为控制鸡生长、屠体性状主基因的侯选基因,以明显肉鸡和丝毛乌骨鸡杂交产生的F2代鸡群为实验材料。通过PCR-RFLP方法对IGF-Ⅱ基因进行多态性检测。在该基因外显子2中发现一处碱基突变,可由内切酶Aci-I酶切证实,但未导致氨基酸改变。对F2鸡群个体进行了基因型鉴定,结果经方差分析显示;该基因对一些生长、屠体性状有显著性影响（如胸角宽、腺胃重、半净膛重等）。表明该基因可能调控鸡生长、屠体性状的表达,或与控制生长、屠体性状的主要因连锁。     

^3H—胸腺嘧啶核苷参入法测定胰岛素促生长活性

利用＾３Ｈ－胸腺嘧啶核苷参入方法,在２４孔板和９６孔板培养的小鼠乳腺癌细胞ＧＲ２Ｈ６中,建立了胰岛素促细胞生长活性的测定体系。这一方法具有操作简便、周期较短和便于进行大量样品分析和测试等优点,它为研究胰岛素促生长功能与结构的关系提供了适当的新研究体系。     

嵌合分子(DHT-PROTAC)在前列腺癌研究中的进展

前列腺癌多发于老年男性,已成为老年男性常见肿瘤之一。内分泌治疗目前是晚期前列腺癌主要治疗方法,但仍避免不了前列腺癌最终进展成激素非依赖性前列腺癌,导致内分泌治疗的失败。当前,对前列腺癌细胞株的AR表达的研究,主要集中在DNA水平及mRNA水平,而对AR蛋白翻译后调控的研究较少。近些年来,嵌合分子(DHT-PROTAC)是基于蛋白水平,调控AR蛋白的表达,成为研究前列腺癌转归新的热点。DHT-PROTAC是一种新型人工合成的异型双功能小分子;这种小分子是DHT与泛素连接酶E3识别基团的嵌合体,它不仅能与AR结合,而且能在结合后,诱导AR的泛素化,从而通过泛素-蛋白酶途径降解AR;本文介绍了嵌合分子的作用原理,回顾了近些年前列腺癌的治疗进展,分析了嵌合分子将来在前列腺癌治疗中的应用前景。     

Bovine Chromaffin Cells Have Insulin-Like Growth Factor-I (IGF-I) Receptors: IGF-I Enhances Catecholamine Secretion

The binding of 125I-insulin-like growth factor-I (125I-IGF-I) to bovine chromaffin cells was measured. Chromaffin cell cultures contained 111,000 +/- 40,000 IGF-I binding sites/cell. These sites bound IGF-I with a KD of 1.1 +/- 0.3 nM and had a much lower affinity for insulin. Cross-linking studies showed that 125I-IGF-I bound to a protein that had an Mr of approximately 125,000, similar to the Mr of the alpha subunit of the IGF-I receptor in other tissues. Cells cultured with IGF-I (10 nM) for 4 days exhibited an almost twofold increase in high K+-evoked catecholamine secretion. Insulin was much less potent than IGF-I in enhancing catecholamine secretion. These data indicate that binding of IGF-I to its receptors on chromaffin cells can modulate the function of these cells.     

Insulin-Like Growth Factor-I Enhances Tyrosine Hydroxylase Activation in Bovine Chromaffin Cells

Previous studies have shown that insulin-like growth factor-I (IGF-I) enhances secretagogue-stimulated Ca2+ uptake and catecholamine release in bovine chromaffin cells. This report describes the effect of IGF-I on the activity of tyrosine hydroxylase (tyrosine 3-monooxygenase, EC 1.14.16.2), the major regulatory enzyme in the pathway of catecholamine biosynthesis. Tyrosine hydroxylase activity was assayed by measuring 3,4-dihydroxyphenylalanine (Dopa) accumulation in the presence of brocresine, an inhibitor of Dopa decarboxylase. Chromaffin cells cultured in serum-free medium produced approximately 40% less Dopa when stimulated by 55 mM K+ than did cells that had been cultured in the presence of serum. Incubation of cells for 3 days in serum-free medium containing 10 nM IGF-I restored high K(+)-stimulated Dopa accumulation to a level comparable to that seen in cells cultured continuously in serum-containing medium. In eight experiments, IGF-I increased high K(+)-stimulated Dopa accumulation (expressed as picomoles per minute per milligram of protein) by 96 +/- 13%. IGF-I increased the protein content of chromaffin cells by approximately 30%; consequently, its effect on tyrosine hydroxylase activity was even greater when Dopa synthesis was expressed as picomoles per minute per 10(7) cells. IGF-I also enhanced the rate of Dopa accumulation in cells stimulated by dimethylphenylpiperazinium, 8-bromo-cyclic AMP, phorbol 12,13-dibutyrate, or Ba2+. The effect of IGF-I on high K(+)-stimulated tyrosine hydroxylase activity was measurable when enzyme activity was assayed in vitro, suggesting that this effect was due to a stable modification of the enzyme.(ABSTRACT TRUNCATED AT 250 WORDS)     

胰岛素B链C端及B29Lys氨基在胰岛素促生长功能中的作用

利用结晶紫测定细胞生长的方法,在９６孔板培养的小鼠乳腺癌细胞ＧＲ２Ｈ６中,建立了胰岛素促细胞生长活力的测定体系。该方法具有灵敏度高,重复性好,操作简便,周期短及便于大量样品分析测试的优点。利用该方法研究了胰岛素Ｂ链Ｃ端延长与缩短的类似物和胰岛素侧链氨基对胰岛素促生长活性的影响。结果显示,胰岛素Ｂ链Ｃ端在胰岛素的促生长活性中有重要作用;Ｂ链２９Ｌｙｓ氨基对促生长活性也有较大贡献。     

组织型纤溶酶原激活剂A链与尿激酶原B链嵌合分子的构建与表达

利用 Ｄ Ｎ Ａ 重组技术和定位删除技术,将组织型纤溶酶原激活剂（ｔ Ｐ Ａ）的 Ａ 链（ Ｓｅｒｌ Ｔｈｒ２６３）基因与尿激酶原（ｐｒｏ Ｕ Ｋ）的 Ｂ链（ Ｓｅｒ１３８ Ｌｅｕ４１１）基因相连,得到嵌合分子基因ｔｕ ｐａ,并在昆虫杆状病毒系统中进行表达,表达量可达 ５００ Ｉ Ｕ／ｍ ｌ．经单克隆抗体免疫亲和层析纯化细胞表达上清液,得到ｔｕ Ｐ Ａ 嵌合分子,其比活为 ２００ ０００ Ｉ Ｕ／ｍ ｇ 蛋白． Ｓ Ｄ Ｓ Ｐ Ａ Ｇ Ｅ 及 Ｗ ｅｓｔｅｒｎ ｂｌｏｔ 鉴定证明此表达产物分子量约为 ６０ ｋ Ｄ,与预期值相符．纤维蛋白平板测活及纤维蛋白亲和性分析初步证明,此嵌合分子的溶纤活性与ｐｒｏ Ｕ Ｋ 相近,而纤维蛋白亲和性高于 ｐｒｏ Ｕ Ｋ．     

Induction of Gene Expression of the Catecholamine-Synthesizing Enzymes by Insulin-Like Growth Factor-I

Abstract: The effects of insulin-like growth factor-I (IGF-I) on gene expression and the activities of the three enzymes specific for catecholamine biosynthesis, tyrosine hydroxylase (TH), dopamine β-hydroxylase (DBH), and phenylethanolamine N -methyltransferase (PNMT), were determined in bovine adrenomedullary chromaffin cells primary cultured in serum-free medium. The mRNA level of TH was maximally elevated in the presence of IGF-I by 3.1 ± 0.4-fold after 48 h, DBH by 5.1 ± 0.3-fold in 24 h, and PNMT by 2.8 ± 0.5-fold in 72 h. In addition, the activity of TH was increased by 77%, DBH by 70%, and PNMT by 23% in IGF-I-exposed cultures. In the absence of the growth factor, the mRNA levels of TH and DBH were decreased to 45 ± 10% and 35 ± 12% of the time-zero control within 48 h while PNMT mRNA was decreased to 82 ± 5% only after 72 h. When the cells were cotreated with the protein tyrosine kinase inhibitor genistein, DBH induction by IGF-I was suppressed, confirming that the effect is mediated by tyrosine kinase. Cotreatment with the protein kinase A (PKA) inhibitor H89 caused complete reversal of the IGF-I-induced DBH increase and the effects of IGF-I treatment and PKA activation by forskolin were not additive, suggesting that PKA is involved in the signaling initiated by IGF-I in these cells.     

Characterization of Insulin-Like Growth Factor-I Receptors in PC 12 Pheochromocytoma Cells and Bovine Adrenal Medulla

Competitive binding studies indicated that PC12 cells have receptors for insulin-like growth factor-I (IGF-I). There are approximately 11,000 +/- 1,500 IGF-I receptors/cell; these receptors have an apparent KD for IGF-I of 7.2 +/- 0.6 nM. Covalent cross-linking of 125I-IGF-I to PC12 cells labeled a 125,000-130,000-Mr protein, presumably the alpha-subunit of the IGF-I receptor. Although PC12 cells also have insulin receptors, the 125I-IGF-I appeared to be cross-linked to IGF-I receptors, because 100 nM IGF-I competed for labeling but 100 nM insulin did not. Bovine chromaffin cells also have IGF-I receptors. The protein tyrosyl kinase activity of IGF-I receptors from bovine adrenal medulla and PC12 cells was examined after purification of the receptors by wheat germ agglutinin-Sepharose chromatography. IGF-I (10 nM) stimulated autophosphorylation of the beta-subunits of the IGF-I receptors from both preparations; the beta-subunits from both sources had Mr values of approximately 97,000. IGF-I also stimulated phosphorylation of the synthetic substrate poly(Glu:Tyr)4:1 by both receptor preparations. IGF-I (IC50 of approximately 0.2 nM) was much more potent than insulin at stimulating phosphorylation of poly(Glu:Tyr) by the bovine adrenal medulla preparation. A maximal concentration of IGF-I (10 nM) increased phosphorylation approximately threefold. IGF-I was slightly more effective than insulin at stimulating the phosphorylation of poly(Glu:Tyr) by the PC12 cell receptor preparation, but neither ligand produced a maximal effect at concentrations up to 100 nM. This result probably reflects the presence of comparable numbers of IGF-I and insulin receptors on PC12 cells.(ABSTRACT TRUNCATED AT 250 WORDS)     

一种耐铀植物促生菌的筛选及促生特性研究

采用富集培养法和LB平板法从铀尾矿污染区蓼科植物酸模根部中筛选和分离一株具有较强铀耐受能力的细菌菌株,通过特征反应和平均吸光度法分析其生长特性和不同培养条件下植物促生特性。结果表明:该菌株可在铀浓度350 mg/kg(土)条件下生长。具有较强的分泌IAA能力,普通条件下24 h产IAA 40.21 mg/L,最佳产IAA条件为温度为35℃,pH 7,转速为150 r/min,氮源为酵母膏,碳源为甘油;兼具ACC脱氨能力,普通条件下24 h产ACC酶活为0.32 U/μg,最佳的ACC酶活条件为温度为30℃,pH 7,转速180 r/min。结合形态学特征,生理生化初步特征和16s rDNA序列确定菌株为木糖氧化无色杆菌。不同铀浓度的盆栽实验接种该菌种能使苜蓿干重分别提高17.9%-110.4%;对铀的富集率分别提高12.2%-180.6%。     

Effects of Capsaicin and Isoflavone on Blood Pressure and Serum Levels of Insulin-Like Growth Factor-I in Normotensive and Hypertensive Volunteers with Alopecia

Insulin-like growth factor-I (IGF-I) reduces arterial blood pressure. Since administration of capsaicin and isoflavone increases serum levels of IGF-I by sensory neuron stimulation in subjects with alopecia, it is possible that administration of capsaicin and isoflavone reduces arterial blood pressure in patients with hypertension. Systolic and diastolic blood pressure (BP) and serum levels of IGF-I were determined before and at 1, 3, and 5 months after administration of capsaicin and isoflavone in 42 volunteers with alopecia, 29 normotensive and 13 hypertensive volunteers. Neither systolic nor diastolic BP changed in the normotensive volunteers after combined administration of capsaicin and isoflavone. In contrast, systolic and diastolic BP was significantly reduced in hypertensive volunteers after administration of capsaicin and isoflavone. Serum levels of IGF-I significantly increased in both normotensive and hypertensive volunteers after administration of capsaicin and isoflavone. These observations suggest that administration of capsaicin and isoflavone might reduce BP in hypertensive, but not in normotensive subjects, probably by increasing serum levels of IGF-I.     

Expression of Insulin-Like Growth Factor-I Receptor and Transferrin Receptor By Breast Cancer Cells In Pleural Effusion Smears

Smear preparations were made from cells harvested from pleural fluid from 90 patients with breast cancer and stained for transferrin receptor (TRFr) and insulin-like growth factor-I receptor (IGF-Ir) using an immunocytochemical technique. the results were correlated with those from 36 benign effusion smears. In malignant smears from the breast cancer cases TRFr was demonstrated in 84.4% of the cellular deposits and IGF-Ir in 91.1%. TRFr was demonstrated in two (11%) of the tuberculous effusion smears and in six (100%) effusions from patients with collagen disease. IGF-Ir was not demonstrated in any of the smears from patients with benign disease. the sensitivity and specificity of TRFr staining were 84.4% and 77.7%, respectively, and for IGF-Ir staining were 91.1% and 100%, respectively. the underlying metabolic changes in the tumour cells which give rise to positive staining with these markers are discussed. Les préparations cytologiques ont été obtenues à partir de cellules recueillies dans le liquide pleural chez 90 patientes ayant un cancer du sein puis ont fait I'objet de techniques immunocytochimiques pour mettre en évidence les récepteurs de la Transferrine (TRF-r) et du facteur de croissance Insulin Like-I (IGF-Ir). Les résultats ont été corrélés avec ceux obtenus sur 36 épanchements bénins. Dans les étalements provenant de patientes traitées pour cancer du sein, TRF-r est positif dans 84,4% des groupements cellulaires et I'IGF-Ir dans 91,1%. Une activité pour le TRF-r est observée dans deux cas (11%) d'epanchements tuberculeux et dans les 6 cas (100Y0) d'épanchement survenant chez des patients atteints de collagénose. Aucune activité IGF-Ir n'est présente dans les cellules des épanchements des patients atteints d'affection bénigne. La sensibilité et la spécificité de I'activité TRF-r sont de 84,4% et de 77% respectivement, celles de I'activité IGF-Ir étant de 91,1% et de 100% respectivement. Les modifications métaboloques sous-jacentes á la positivité en immunocytologie des cellules tumorales avec ces marqueurs sont discutiés. Ausstriche von Pleuraergüssen von 90 Patientinnen mit Mammakarzinom wurden hinsichtlich Tranferrinrezeptoren (TRF-r) und Insulinwachstumsrezeptor (IGF-r) untersucht. 36 benigne Ergüsse dienten als Vergleich. In tumorösen Ergüssen waren TFGr in 84,4% und IGFr in 91,1% nachweisbar. TRFr war ausserdem in 2 (11Y0) der tuberkulösen und 6 (100%) der rheumatischen Ergüsse positiv währen IGFr in keinem der benignen Fälle positiv ausfiel. Sensitivität und Spezifität waren für TRFr 84,4% bzw. 77,7% und IGFr 91,1y0 bzw. 100%. Die metabolischen Veränderungen der Tumorzellen werden diskutiert.